Bacillus Calmette-Guérin (BCG)
BCG is a vaccine that was introduced in the fight against tuberculoses in 1921. It involves highly weakened tubercolosies microbes that are supposed to have a strong immune reaction against cancer.
In an aggressive form of bladder cancer (transitional cell carcinoma in situ) the BCG vaccine causes a strong immune reaction in the form of a healing fever.
Dr. Burton Waisbren (leader of the Waisbren Clinic in Milwaukee) explained that the main advantage of BCG and other immune therapies like Coley’s toxin or transfer factors (TF) is the capability of preventing the recurrence of secondary cancer. Also many German doctors such as Professor Hackethal have had positive experiences BCG.
Transfer factors (that are produced from the immune system of healthy donors) have been able to demonstrably improve the clinical reaction of breast cancer patients (Book of the National Academy of Science, 1974 – see also transfer factors). A study by Dr. Waisbren with 22 lung cancer patients showed that a combination of the aforementioned mentioned vaccines was helpful in delaying the recurrence of lung cancer. In his study, cancer patients who received the vaccine lived 9 months longer than patients in a control group who were not given the vaccine. In Oncology Magazine in 1995 a study of bladder cancer (transitional cell carcinoma in situ) was published in which 20% of the patients were still alive after 5 years. In the group of patients who were treated with BCG, 80% were still alive.
Personal opinion: BCG generates fever which is known to have a healing influence on cancer. However only a few physicians use BCG, due to lack of knowledge, and due to the possible side effects.